The Impact of Pharmacists on Telehealth During Transitions of Care: A Literature Review

J Pharm Pract. 2023 Oct;36(5):1225-1231. doi: 10.1177/08971900221104707. Epub 2022 May 21.

Abstract

Purpose: To provide a review of pharmacists' impact during transitions of care (TOC) visits utilizing telehealth. Methods: An electronic literature review was conducted on studies that addressed pharmacists' impact on telehealth during TOC. Articles included in the review were randomized or observational studies, cohort studies, case series or case reports, literature reviews, or pilot studies conducted on adults. Articles investigating children were excluded from the review. Results: Of the articles identified, 14 studies met the eligibility criteria and were selected for the literature review. All of the studies were published in English between 2013 and 2021. Most were conducted in the United States of America (n = 12) with 1 conducted in Ireland (n = 1) and 1 in Australia (n = 1). The majority of telehealth monitoring was conducted via phone (n = 8), video conferencing (n = 3), or both (n = 2) in patients' homes by pharmacists alone (n = 8) while the remaining studies involved telemonitoring by a combination of pharmacy fellows, residents, and/or students. These findings showed that pharmacist intervention in patient care showed improved patient outcomes and goal markers for a variety of health conditions as well as lower rates of 30 day, 60 day, and 90 day hospital readmissions. Conclusion: Pharmacist involvement in telehealth monitoring had a positive impact on TOC interventions and overall patient outcomes including decreased hospital readmissions and increased patient medication adherence.

Keywords: and virtual; cardiovascular; hospital discharge; pharmacists; pharmacy; readmission; telehealth; telemonitoring; transitions of care.

Publication types

  • Review

MeSH terms

  • Adult
  • Child
  • Humans
  • Medication Reconciliation
  • Patient Discharge
  • Patient Readmission
  • Pharmacists
  • Pharmacy Service, Hospital*
  • Randomized Controlled Trials as Topic
  • Telemedicine*
  • United States